The Ahmed glaucoma valve in neovascular glaucoma (an aos thesis)

Transactions of the American Ophthalmological Society

Volumn 107, Issue , 2009, Pages 325-342

  Netland, Peter A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; LIGHT; MALE; NEOVASCULAR GLAUCOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; VISION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; KAPLAN-MEIERS ESTIMATE; LIFE TABLES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; VISION DISORDERS; YOUNG ADULT;

EID: 77949417947     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Duke-Elder S. Glaucoma secondary to vascular diseases. Haemorrhagic glaucoma. In: Duke-Elder S, ed. System of Ophthalmology, Volume XI: Diseases of the Lens and Vitreous, Glaucoma and Hypotony, Section III: Glaucoma and Hypotony. St Louis: CV Mosby; 1969:667-677.
2. Weber PA. Neovascular glaucoma. Current management. Surv Ophthalmol 1981;26:149-153.
3. Hayreh SS. Neovascular glaucoma. Prog Retinal Eye Res 2007;26:470-485.
4. Sivak-Callcott JA, O'Day DM, Gass DM, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108:1767-1778.
5. Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma. Etiologic considerations. Ophthalmology 1984;91:315-320.
6. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol 1997;124:521-529.
7. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology 1998;105:232-237.
8. Chen KH, Wu CC, Roy S, et al. Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 1999;40:2627-2632.
9. Aiello LM, Wand M, Liang G. Neovascular glaucoma and vitreous hemorrhage after cataract surgery in patients with diabetes mellitus. Ophthalmology 1983;90:814-820.
10. Rice TA, Michels RG, Maguire MG, Rice EF. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1983;95:1-11.
11. Weinreb RN, Wasserstrom JP, Parker W. Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy. Arch Ophthalmol 1986;104:730-731.
12. Callahan MA. Photocoagulation and rubeosis iridis. Am J Ophthalmol 1974;78:873-874.
13. Wand M, Dueker DK, Aiello LM, Grant WM. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol 1978;86:332-339.
14. Murphy RP, Egbert PR. Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 1979;97:700-702.
15. Tasman W, Magargal LE, Augsburger JJ. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 1980;87:400-402.
16. Pavan PR, Folk JC, Wengeist TA, Hermsen VM, Watzke RC, Montague PR. Diabetic rubeosis and panretinal photocoagulation. A prospective, controlled masked trial using iris fluorescein angiography. Arch Ophthalmol 1983;101:882-884.
17. Magargal LE, Brown GC, Augsburger JJ, Donoso LA. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology 1982;89:780-784.
18. Hayreh SS, Klugman MR, Podhajskuy P, et al. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990;228:281-296.
19. Brodell LP, Olk RJ, Arribas NP, et al. Neovascular glaucoma: a retrospective analysis of treatment with peripheral panretinal cryotherapy. Ophthalmic Surg 1987;18:200-206.
20. Sihota R, Sandramouli S, Sood NN. A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma. Ophthalmic Surg 1991;22:256-259.
21. Vernon SA, Cheng H. Panretinal cryotherapy in neovascular disease. Br J Ophthalmol 1988;72:401-405.
22. Tsai JC, Bloom PA, Franks WA, Khaw PT. Combined transscleral diode laser cyclophotocoagulation and transscleral retinal photocoagulation for refractory neovascular glaucoma. Retina 1996;16:164-166.
23. Flaxel CJ, Larkin GB, Broadway DB, Allen PJ, Leaver PK. Peripheral transscleral retinal diode laser for rubeosis iridis. Retina 1997;17:421-429.
24. Charles S. Endophotocoagulation. Retina 1981;1:117-120.
25. Bartz-Schmidt KU, Thumann G, Psichias A, Krieglstein GK, Heimann K. Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 1999;237:969-975.
26. Hayreh SS, Podhajsky P. Ocular neovascularization with retinal vascular occlusion. Arch Ophthalmol 1982;100:1585-1596.
27. Ohnishi Y, Ishibashi T, Sagawa T. Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 1994;232:199-204.
28. Stefaniotou M, Paschides CA, Psilas K. Panretinal cryopexy for the management of neovascularization of the iris. Ophthalmologica 1995;209:141-144.
29. Ritch R, Barkana Y, Liebmann JM. Special therapeutic situations. In: Netland PA, ed. Glaucoma Medical Therapy. Principles and Management. New York: Oxford University Press; 2008:215-232.
30. Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008;115:1571-1580.
31. Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008;28:696-702.
32. Allen RC, Bellows AR, Hutchinson BT, Murphy SD. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 1982;89:1181-1187.
33. Mietz H, Raschka B, Krieglstein GK. Risk factors for failures of trabeculectomies performed without antimetabolites. Br J Ophthalmol 1999;83:814-821.
34. Wand M. Neovascular glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St Louis: CV Mosby; 1996:1073-1129.
35. Tsai JC, Feuer WJ, Parrish RK II, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 1995;102:887-892.
36. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology 1995;102:1263-1269.
37. Kiuchi Y, Nakae K, Saito Y, Ito S, Ito N. Pars plana vitrectormy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 2006;244:1627-1632.
38. Elgin U, Berker N, Batman A, Simsek T, Cankaya B. Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. J Glaucoma 2006;15:466-470.
39. Sisto D, Vetrugno M, Trabucco T, Cantatore F, Ruggeri G, Sborgia C. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand 2007;85:267-271.
40. Al-Obeidan SA, Osman EA, Al-Amro SA, Kangave D, Abu El-Asrar AM. Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin C for neovascular glaucoma. Eur J Ophthalmol 2008;18:758-764.
41. Borisuth NS, Phillips B, Krupin T. The risk profile of glaucoma filtration surgery. Curr Opin Ophthalmol 1999;10:112-116.
42. Katz LJ, Costa VP, Spaeth GL. Filtration surgery. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St Louis: Mosby; 1996:1661-1702.
43. Hong C-H, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol 2005;50:48-60.
44. Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? A randomized clinical trial of single-plate versus doubleplate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology 1992;99:1512-1519.
45. Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol 2001;85:689-695.
46. Smith MF, Doyle JW, Sherwood MB. Comparison of the Baerveldt glaucoma implant with the double-plate Molteno drainage implant. Arch Ophthalmol 1995;113:444-447.
47. Siegner SW, Netland PA, Urban RC Jr, et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology 1995;102:1298-1307.
48. 2 Baerveldt implant: longer term results. Is bigger better? Ophthalmology 1999;106:2312-2318.
49. Al-Aswad LA, Netland PA, Bellows AR, et al. Clinical experience with the double-plate Ahmed glaucoma valve. Am J Ophthalmol 2006;141:390-391.
50. Jacob JT, Burgoyne CF, McKinnon SJ, et al. Biocompatibility response to modified Baerveldt glaucoma drains. J Biomed Mater Res 1998;43:99-107.
51. Boswell CA, Noecker RJ, Mac M, et al. Evaluation of an aqueous drainage glaucoma device constructed of ePTFE. J Biomed Mater Res 1999;48:591-595.
52. Ayyala RS, Michelini-Norris B, Flores A, et al. Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol 2000;118:1081-1084.
53. Ishida K, Netland PA, Costa VP, Shiroma L, Khan B, Ahmed II. Comparison of polypropylene and silicone Ahmed glaucoma valves. Ophthalmology 2006;113:1320-1326.
54. Hinkle DM, Zurakowski D, Ayyala RS. A comparison of the polypropylene plate Ahmed glaucoma valve to the silicone plate Ahmed glaucoma flexible valve. Eur J Ophthalmol 2007;17:696-701.
55. Mackenzie PJ, Schertzer RM, Isbister CM. Comparison of silicone and polypropylene Ahmed glaucoma valves: two-year follow-up. Can J Ophthalmol 2007;42:227-232.
56. Law SK, Nguyen A, Coleman AL, Caprioli J. Comparison of safety and efficacy between silicone and polypropylene Ahmed glaucoma valves in refractory glaucoma. Ophthalmology 2005;112:1514-1520.
57. Brasil MV, Rockwood EJ, Smith SD. Comparison of silicone and polypropylene Ahmed glaucoma valve implants. J Glaucoma 2007;16:36-41.
58. Huang MC, Netland PA, Coleman AL, Siegner SW, Moster MR, Hill RA. Intermediate-term clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999;127:27-33.
59. Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers 2002;33:94-101.
60. Tsai JC, Johnson CC, Kammer JA, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology 2006;113:913-917.
61. Syed HM, Law SK, Nam SH, Li G, Caprioli J, Coleman A. Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison. J Glaucoma 2004;13:38-45.
62. 2 glaucoma implant. Ophthalmology 2008;115:1141-1147.
63. Molteno AC, Staughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S Afr Med J 1976;50:881-885.
64. Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation. A prospective randomized clinical trial. Ophthalmology 2004;111:1071-1076.
65. Cantor L, Burgoyne J, Sanders S, et al. The effect of mitomycin-C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma 1998;7:240-246.
66. Perkins TW, Cardakli UF, Eisele JR, et al. Adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1995;102:91-97.
67. Lee D, Shin DH, Birt CM, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1997;104:2126-2135.
68. Trible JR, Brown DB. Occlusive ligature and standardized fenestration of a Baerveldt with and without antimetabolites for early postoperative intraocular pressure control. Ophthalmology 1998;105:2243-2250.
69. Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol 2008;146:276-284.
70. Minckler DS, Francis BA, Hodapp EA, et al. Aqueous shunts in glaucoma. A report by the American Academy of Ophthalmology. Ophthalmology 2008;115:1089-1098.
71. Ishida K, Netland PA. Ahmed glaucoma valve implantation in African American and white patients. Arch Ophthalmol 2006;124:800-806.
72. Freedman J, Rubin B. Molteno implant as a treatment for refractory glaucoma in black patients. Arch Ophthalmol 1991;108:1417-1420.
73. Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol 1999;128:198-204.
74. 2 implant. Ophthalmology 2006;113:766-772.
75. Al-Jazzaf AM, Netland PA, Charles S. Incidence and management of elevated intraocular pressure after silicone oil injection. J Glaucoma 2005;14:40-46.
76. Ishida K, Ahmed IIK, Netland PA. Ahmed glaucoma valve surgical outcomes in eyes with and without silicone oil endotamponade. J Glaucoma 2009;18:325-330.
77. Netland PA, Denton NC. Uveitic glaucoma. Contemp Ophthalmol 2006;5:1-6.
78. DaMata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999;106:2168-2172.
79. Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology 1998;105:751-757.
80. Rachmiel R, Trope GE, Buys YM, Flanagan JG, Chipman ML. Intermediate-term outcome and success of superior versus inferior Ahmed glaucoma valve implantation. J Glaucoma 2008;17:584-590.
81. Ishida K, Mandal AK, Netland PA. Glaucoma drainage implants in pediatric patients. Ophthalmol Clin North Am 2005;18:431-442.
82. Autrata R, Helmanova I, Oslejskova H, Vondracek P, Rehurek J. Glaucoma drainage implants in the treatment of refractory glaucoma in pediatric patients. Eur J Ophthalmol 2007;17:928-937.
83. 2 Baerveldt glaucoma implants. Ophthalmology 2001;108:621-626.
84. Souza C, Tran DH, Loman J, Law SK, Coleman AL, Caprioli J. Long-term outcomes of Ahmed glaucoma valve implantation in refractory glaucomas. Am J Ophthalmol 2007;144:893-900.
85. Molteno AC, Van Rooyen MM, Bartholomew RS. Implants for draining neovascular glaucoma. Br J Ophthalmol 1977;61:120-125.
86. Mermoud A, Salmon JF, Alexander P, Straker C, Murray AD. Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 1993;100:897-902.
87. Every SG, Molteno ACB, Bevin TH, Herbison P. Long-term results of Molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol 2006;124:355-360.
88. Krupin T, Kaufman P, Mandell AI, et al. Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma. Am J Ophthalmol 1983;95:775-782.
89. Mastropasqua L, Carpineto P, Ciancaglini M, Zuppardi E. Long-term results of Krupin-Denver valve implants in filtering surgery for neovascular glaucoma. Ophthalmologica 1996;210:203-206.
90. Sidoti PA, Dunphy TR, Baerveldt G, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995;102:1107-1118.
91. Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye 2007;21:65-70.
92. Krupin T, Kaufman P, Mandell A, et al. Filtering valve implant surgery for eyes with neovascular glaucoma. Am J Ophthalmol 1980;89:338-343.
93. Schocket SS, Lakhanpal V, Richards RD. Anterior chamber tube shunt to an encircling band in the treatment of neovascular glaucoma. Ophthalmology 1982;89:1188-1194.
94. Chihara E, Kubota H, Takanashi T, Nao-i N. Outcome of White pump shunt surgery for neovascular glaucoma in Asians. Ophthalmic Surg 1992;23:666-671.
95. Parrish R, Herschler J. Eyes with end-stage neovascular glaucoma. Natural history following successful modified filtering operation. Arch Ophthalmol 1983;101:745-746.
96. Scott IU, Alexandrakis G, Flynn HW Jr, et al. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma. Am J Ophthalmol 2000;129:334-341.
97. Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, Riazi-Esfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2007;38:292-300.
98. Chalam KV, Gandham S, Gupta S, Tripathi BJ, Tripathi RC. Pars plana modified Baerveldt implant versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmic Surg Lasers 2002;33:383-393.
99. Eid TE, Katz LJ, Spaeth GL, Augsburger JJ. Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmology 1997;104:1692-1700.
100. Nouri-Mandavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol 2003;136:1001-1008.
101. Blanc JP, Molteno AC, Fuller JR, Bevin TH, Herbison P. Life expectancy of patients with neovascular glaucoma drained by Molteno implants. Clin Experiment Ophthalmol 2004;32:360-363.
102. Lima FE, Magacho L, Carvalho DM, Susanna R Jr, Avila MP. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma 2004;13:233-237.
103. Yildirim N, Yalvac IS, Sahin A, Ozer A, Bozca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma. A long-term follow-up. J Glaucoma 2009;18:192-196.
104. Samchyshyn TM, Tsai JC, Joos KM. Supplemental transscleral diode laser cyclophotocoagulation after aqueous shunt placement in refractory glaucoma. Ophthalmology 2002;109:1078-1084.
105. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007;18:502-508.
106. Lynch SS, Cheng CM. Bevacizumab for neovascular ocular diseases. Ann Pharmacother 2007;41:614-625.
107. Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 2006;90:1542-1547.
108. Grisanti S, Biester S, Peters S, et al. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 2006;142:158-160.
109. Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolk S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006;142:1054-1056.
110. Mason JO 3rd, Albert MA Jr, Mays A, Vail R. Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina 2006;26:839-841.
111. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 2006;37:144-146.
112. Chilov MN, Grigg JR, Playfair TJ. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol 2007;35:494-496.
113. Davidorf FH, Mourser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006;26:354-356.
114. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 2007;16:437-439.
115. Vatavuk Z, Bencic G, Mandic Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007;17:269-271.
116. Costagliola C, Cipollone U, Rinaldi M, della Corte M, Semeraro F, Romano MR. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout the 12-month follow-up. Br J Clin Pharmacol 2008;66:667-673.
117. Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S. Inracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol 2008;18:255-262.
118. Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006;142:155-158.
119. Kitnarong N, Chindasub P, Metheetrairut A. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Adv Ther 2008;25:438-443.
120. Lupinacci APC, Calzada JI, Rafieetery M, Charles S, Netland PA. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab. Adv Ther 2009;26:208-216.